Author
The University of Texas MD Anderson Cancer CenterORCID 0000-0003-4328-1044Unclaimed ORCID profile · follow to get notified of new preprints
Mutual co-authors in cluster
5 papers
Recent·Most cited
Yongkun Wei, Minghui Liu, Er-Yen Yen…·Haoqiang Ying
This study identifies CD24 as an actionable signal activated by KRASG12C inhibition in pancreatic cancer, enhancing macrophage phagocytosis and sensitizing tumors to therapy.
Luigi Perelli, Li Zhang, Sarah M. Mangiameli…·Giannicola Genovese
This study investigates the role of EMT in pancreatic cancer evolution and metastasis, showing that mesenchymal lineages drive chromosomal instability and clonal evolution.
Oscar Eduardo. Villarreal, Yixin Xu, Ha Tran…·Scott Kopetz
The paper identifies adaptive plasticity tumor (APT) cells that reduce response to MAPK inhibitors in colorectal cancer by increasing stemness and ASCL2 expression, and shows that targeting APT cells improves therapy efficacy.
Francesca Citron, I-Lin Ho, Chiara Balestrieri…·Giulio Francesco Draetta
This study shows that disrupting the WRAD core in pancreatic cancer leads to DNA replication errors, immune response activation, and improved response to immune checkpoint inhibitors.
Shaolong Cao, Jennifer Rui Wang, Shuangxi Ji…·Wenyi Wang
The paper quantifies tumor-specific total mRNA expression from bulk data and shows its association with clinical outcomes across 15 cancer types.